title: Assembly of bio-nanoparticles for double controlled drug release.
abstract: A critical limiting factor of chemotherapy is the unacceptably high toxicity. The use of nanoparticle based drug carriers has significantly reduced the side effects and facilitated the delivery of drugs. Source of the remaining side effect includes (1) the broad final in vivo distribution of the administrated nanoparticles, and (2) strong basal drug release from nanoparticles before they could reach the tumor. Despite the advances in pH-triggered release, undesirable basal drug release has been a constant challenge under in vivo conditions. In this study, functionalized single walled carbon nanohorn supported immunoliposomes were assembled for paclitaxel delivery. The immunoliposomes were formulated with polyethylene glycol, thermal stable and pH sensitive phospholipids. Each nanohorn was found to be encapsulated within one immunoliposome. Results showed a highly pH dependent release of paclitaxel in the presence of serum at body temperature with minimal basal release under physiological conditions. Upon acidification, paclitaxel was released at a steady rate over 30 days with a cumulative release of 90% of the loaded drug. The drug release results proved our hypothesized double controlled release mechanism from the nanoparticles. Other results showed the nanoparticles have doubled loading capacity compared to that of traditional liposomes and higher affinity to breast cancer cells overexpressing Her2 receptors. Internalized nanoparticles were found in lysosomes.
authors.affiliation: Department of Biological Systems Engineering, Virginia Tech, Blacksburg, Virginia, United States of America.
authors.forename: Wei
authors.initials: W
authors.lastname: Huang
authors.forename: Jianfei
authors.initials: J
authors.lastname: Zhang
authors.forename: Harry C
authors.initials: HC
authors.lastname: Dorn
authors.forename: Chenming
authors.initials: C
authors.lastname: Zhang
mesh_terms: D002460:Cell Line; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008081:Liposomes / Q000737:chemistry; D018613:Microscopy, Confocal; D046529:Microscopy, Electron, Transmission; D053761:Nanocomposites / Q000737:chemistry*; D053758:Nanoparticles / Q000737:chemistry*; D017239:Paclitaxel / Q000008:administration & dosage; D010316:Particle Size; D011092:Polyethylene Glycols / Q000737:chemistry; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D044967:Serum; D012995:Solubility
chemical_list: D003692:Delayed-Action Preparations; D004337:Drug Carriers; D008081:Liposomes; D017239:Paclitaxel; D011092:Polyethylene Glycols; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human
references.citation: Adv Drug Deliv Rev. 2002 Sep 13;54(5):631-51
references.pmid: 12204596
references.citation: Nature. 2003 Feb 13;421(6924):756-60
references.pmid: 12610629
references.citation: Nature. 2000 Aug 17;406(6797):747-52
references.pmid: 10963602
references.citation: Nanomedicine. 2010 Apr;6(2):245-56
references.pmid: 19699321
references.citation: Nat Mater. 2011 May;10(5):389-97
references.pmid: 21499315
references.citation: J Control Release. 2005 Dec 10;110(1):20-33
references.pmid: 16289421
references.citation: Eur J Cancer. 2008 Dec;44(18):2806-12
references.pmid: 19022660
references.citation: J Control Release. 2011 Feb 28;150(1):2-22
references.pmid: 21095210
references.citation: Nanomedicine. 2005 Mar;1(1):22-30
references.pmid: 17292054
references.citation: Biomaterials. 2010 May;31(13):3657-66
references.pmid: 20138662
references.citation: Int J Pharm. 2011 Aug 30;415(1-2):34-52
references.pmid: 21640806
references.citation: Crit Rev Oncol Hematol. 2010 Nov;76(2):99-111
references.pmid: 20097088
references.citation: EMBO J. 2000 Jul 3;19(13):3159-67
references.pmid: 10880430
references.citation: Biomaterials. 2011 May;32(13):3435-46
references.pmid: 21295849
references.citation: Science. 1987 Jan 9;235(4785):177-82
references.pmid: 3798106
references.citation: Biochim Biophys Acta. 1991 Jun 18;1065(2):145-52
references.pmid: 2059649
references.citation: J Control Release. 2009 May 21;136(1):21-9
references.pmid: 19331851
references.citation: Biochim Biophys Acta. 1994 Dec 30;1198(2-3):165-84
references.pmid: 7819273
references.citation: Maturitas. 2012 Sep;73(1):19-26
references.pmid: 22402026
references.citation: Bioconjug Chem. 2011 Jun 15;22(6):1012-6
references.pmid: 21528932
references.citation: J Pharmacol Exp Ther. 2000 Mar;292(3):1071-9
references.pmid: 10688625
references.citation: Anal Biochem. 2005 Jan 15;336(2):213-20
references.pmid: 15620886
references.citation: Nano Lett. 2010 Aug 11;10(8):2843-8
references.pmid: 20698597
references.citation: Biomaterials. 2009 Feb;30(4):603-10
references.pmid: 19012960
references.citation: J Control Release. 2012 Jul 20;161(2):175-87
references.pmid: 21945285
references.citation: Biochim Biophys Acta. 2009 Oct;1788(10):2259-66
references.pmid: 19595666
references.citation: Adv Drug Deliv Rev. 2012 Feb;64(2):179-89
references.pmid: 21983079
references.citation: ACS Nano. 2008 Feb;2(2):213-26
references.pmid: 19206621
references.citation: Biochim Biophys Acta. 2012 Jan;1824(1):22-33
references.pmid: 21914490
references.citation: J Clin Oncol. 2005 Jul 1;23(19):4265-74
references.pmid: 15911866
references.citation: Semin Radiat Oncol. 1998 Jul;8(3):176-82
references.pmid: 9634494
references.citation: Nucl Med Biol. 2008 May;35(4):501-14
references.pmid: 18482688
references.citation: Eur J Cancer. 2008 Oct;44(15):2218-25
references.pmid: 18722111
references.citation: Nanomedicine. 2012 Feb;8(2):147-66
references.pmid: 21703993
references.citation: J Control Release. 2007 Jul 31;120(3):169-77
references.pmid: 17586082
references.citation: J Control Release. 2010 Jun 15;144(3):324-31
references.pmid: 20219607
references.citation: J Pharm Pharmacol. 2005 Oct;57(10):1231-42
references.pmid: 16259751
references.citation: Toxicol Lett. 2009 Sep 28;189(3):177-83
references.pmid: 19397964
references.citation: N Engl J Med. 2001 Mar 15;344(11):783-92
references.pmid: 11248153
references.citation: Nature. 1996 Apr 11;380(6574):561-2
references.pmid: 8606781
references.citation: Biochim Biophys Acta. 2001 Nov 1;1515(1):23-37
references.pmid: 11597349
references.citation: J Am Chem Soc. 2009 Feb 4;131(4):1354-5
references.pmid: 19173660
references.citation: Acad Radiol. 2005 Oct;12(10):1342-50
references.pmid: 16179211
references.citation: Adv Drug Deliv Rev. 1998 Oct 5;34(1):109-119
references.pmid: 10837673